Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease - Top-Institutions - MDSpire

Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease

  • By

  • Nienke P. M. Wassenaar

  • Koen C. van Son

  • Bas Voermans

  • Kirsi M. A. van Eekhout

  • Marian A. Troelstra

  • Stan Driessen

  • Anne Line Mak

  • Julia J. Witjes

  • Anne-Marieke van Dijk

  • Veera Houttu

  • Diona Zwirs

  • Elizabeth Shumbayawonda

  • Max Nieuwdorp

  • Michail Doukas

  • Joanne Verheij

  • Aart J. Nederveen

  • Oliver J. Gurney-Champion

  • Adriaan G. Holleboom

  • March 28, 2026

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Radiology
    • Gastroenterology

  • #2

    University of California, San Diego (UCSD) – NAFLD Research Center
    University of California, San Diego (UCSD) – NAFLD Research Center

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Radiology
    • Metabolic Diseases

  • #3

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Radiology
    • Hepatology
    • Biomedical Imaging

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Radiology
    • Gastroenterology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Hepatology
    • Radiology
    • Gastroenterology

Original Source(s)

Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease

  • by Nienke P. M. Wassenaar, Koen C. van Son, Bas Voermans, Kirsi M. A. van Eekhout, Marian A. Troelstra, Stan Driessen, Anne Line Mak, Julia J. Witjes, Anne-Marieke van Dijk, Veera Houttu, Diona Zwirs, Elizabeth Shumbayawonda, Max Nieuwdorp, Michail Doukas, Joanne Verheij, Aart J. Nederveen, Oliver J. Gurney-Champion, Adriaan G. Holleboom

  • March 28, 2026

Related Content

Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease

Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States

Prediction of Metabolic Dysfunction–Associated Steatotic Liver Disease via Advanced Machine Learning Among Chinese Han Population